Bimekizumab (BKZ) Treatment Resulted in Patients With Axial Spondyloarthritis (axSpA) Maintaining Their Clinical Responses Over 3 Years: Results From Two Phase 3 Studies and Their Open- Label Extension (OLE) (Update)

Bimzelx (bimekizumab-bkzx) - UCB

https://static1.squarespace.com/static/6642bbced8b22f3bcd7949a5/t/6a05b7ce0e0e4a17617431e0/1778759630269/APL_v29_iS2_Rev4.pdf

Andrew Taylor1; Fabian Proft2; Désirée van der Heijde3; Sergio Schwartzman4,5,6; Vanessa Taieb7; Sarah Kavanagh8; Gaëlle Varkas9; Victoria Navarro- Compán10; Xenofon Baraliakos11

May 26, 2026